Navigation Links
Kosan Announces Third Quarter 2007 Financial Results
Date:11/8/2007

g 888.286.8010, access code: 98027185. International callers can dial 617.801.6888, access code: 98027185.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib in patients with multiple myeloma in a registration program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with Herceptin, and as monotherapy in metastatic melanoma. Intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS- 1022), are being evaluated in Phase 1 clinical trials in hematological cancers and in HER2-positive metastatic breast cancer.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors.

Kosan's motilin agonist compound, KOS-2187, licensed to Pfizer, is in a Phase 1 trial in gastroesophageal reflux disease (GERD).

For additional information on Kosan Biosciences, please visit Kosan's website at http://www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include, but are not limited to, statements regarding the further development (including the planned commencement of one or more Phase 2 clinical trials and th
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
3. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
4. Kosan Biosciences to Host Research & Development Day on October 31, 2007
5. Kosan to Reacquire Epothilone Program From Roche
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  The Chicago Bears are excited to announce the ... in an effort to raise awareness of skin cancer. ... SPOT me™ skin cancer screenings at a preseason fan ... SPOT me™ is an educational campaign designed to inform ... of skin cancer, and encourages people to get screened ...
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 BCC Research ... Global Markets for Enzymes in Industrial Applications , the ... to nearly $7.1 billion by 2018, registering a five-year ... is estimated to be recorded in the detergent enzyme ... period. , Enzyme technology has influenced almost every sector ...
(Date:7/30/2014)... Fla. , July 30, 2014  Dyadic ... biotechnology company whose patented and proprietary technologies are ... and other proteins for the bioenergy, bio-based chemical, ... appointment of Thomas "Tom" Dubinski as Vice President ... for leading the financial and information technology operations ...
Breaking Biology Technology:Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4
... June 3 Experts from PAREXEL International Corporation (Nasdaq: ... provider, will address important industry issues at the Drug ... June 21 - 25, 2009 in San Diego, California. ... topics ranging from global development strategies, clinical logistics in ...
... ... Adventus EHC ® Enhanced Natural Attenuation Biotechnology as Demonstrably Superior to Alternatives ... New York, NY ... enterprise for treatment of contaminated soil, sediment and groundwater environments, is proud to announce ...
... from their roots up to their leaves hundreds of feet ... the University of Rochester have created a simple slab of ... at a speed that would make nature envious. , The ... Letters , may prove invaluable in pumping microscopic amounts of ...
Cached Biology Technology:PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting 2PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting 3PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting 4PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting 5PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting 6Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy 2Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy 3Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy 4Scientists create metal that pumps liquid uphill 2Scientists create metal that pumps liquid uphill 3
(Date:7/30/2014)... treatment has been shown to relieve patients, pain. ... transmission between the peripheral and central nervous systems, ... Radiation Medicine, Chinese Academy of Medical Sciences, China ... dorsal root ganglia (DRG) to provide relief for ... 14.8, 29.6 MBq) were implanted separately into the ...
(Date:7/30/2014)... cells types. Researchers would like to understand how to channel ... make up the organs and other structures of living organisms. ... sugars that dangle from proteins on surfaces of cells. , ... has created synthetic molecules that can stand in for the ... the process, they report in the Journal of the ...
(Date:7/30/2014)... 2014 The Nano-Bio Manufacturing Consortium (NBMC), ... Force Research Laboratory (AFRL), has awarded funding for ... University to develop electronics and biometric sensor ... project, with contributions from the University of California, ... ( Endicott, N.Y. ), is scheduled ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3
... University of Colorado Boulder researchers who have adapted a ... time some 2.8 billion years ago when the sun ... have been more prone to catastrophic glaciation than previously ... Eon on Earth that lasted from about 3.8 billion ...
... HEIDELBERG -- EMBO today announces the selection of seven ... The grants will assist the researchers to relocate and ... and Turkey. "The EMBO Installation Grants directly support ... said Gerlind Wallon, Installation Grants Programme Manager and EMBO ...
... In pets and people, the time it takes to diagnose ... of Missouri veterinarian is identifying ways to diagnose pet infections ... resulting test could be used eventually for humans. "Infections ... send samples to a lab and wait three days or ...
Cached Biology News:Early Earth may have been prone to deep freezes, says CU-Boulder study 2Early Earth may have been prone to deep freezes, says CU-Boulder study 3
...
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... full-featured high-performance ICP-MS system designed for flexibility ... Omega II off-axis ion lens, true hyperbolic ... can handle the widest range of sample ... 7500a now includes as standard Agilents unique ...
... DH-2000, except that it uses a deep-UV deuterium ... and comes with a shutter (controlled via a ... The DH-2000 Deuterium Tungsten Halogen Light ... tungsten halogen light sources in a single optical ...
Biology Products: